Results 131 to 140 of about 3,500 (185)

Effects of Janus Kinase Inhibitors on Rheumatoid Arthritis Pain: Clinical Evidence and Mechanistic Pathways. [PDF]

Biomedicines
Belančić A, Sener S, Sener YZ, Fajkić A, Vučković M, Markotić A, Benić MS, Potočnjak I, Pavlović MR, Radić J, Radić M.   +10 more
europepmc   +1 more source

Computational identification of small molecules for increased gene expression by synthetic circuits in mammalian cells. [PDF]

Nat Commun
Pisani M, Calandra F, Rinaldi A, Cella F, Tedeschi F, Boffa I, Vozzi D, Brunetti-Pierri N, Carissimo A, Napolitano F, Siciliano V.   +10 more
europepmc   +1 more source

Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter Cohort. [PDF]

Rheumatol Ther
Celletti E, Di Penta M, Ariani A, Parisi S, Andracco R, Raffeiner B, Ianniello A, Lo Gullo A, Molica Colella AB, Priora M, Paroli M, Lumetti F, Ravagnani V, Girelli F, Vitetta R, Volpe A, Scolieri P, Bezzi A, Ometto F, Visalli E, Farina A, Del Medico P, Bravi E, Colina M, Larosa M, Serale F, Franchina V, Molica Colella F, Ferrero G, Sandri G, Addimanda O, Reta M, Mascella F, Focherini MC, Fiorenza A, Rovera G, Giampietro C, Bernardi S, Mansueto N, Camellino D, Caccavale R, Nucera V, Sabatini E, Del Biondo P, Ditto MC, Platè I, Adorni G, Di Donato E, Santilli D, Lucchini G, Amato G, De Lucia F, Dal Bosco Y, Foti R, Smerilli G, Bianchi G, Foti R, Arrigoni E, Marchetta A, Bixio R, Bruzzese V, Fusaro E, Giuggioli D, Salvarani C, Cipollone F, Becciolini A.   +65 more
europepmc   +1 more source

JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease. [PDF]

Therap Adv Gastroenterol
Fousekis FS, Jefremow A, Katsanos KH, Neurath MF, Atreya R.   +4 more
europepmc   +1 more source

Protocol: Filgotinib in addition to methotrexate versus filgotinib monotherapy in patients with rheumatoid arthritis with an inadequate response to methotrexate: A multicenter, prospective, open-label, randomized controlled trial (FAITHFUL Study). [PDF]

PLoS One
Akiyama M, Hidaka T, Kaneko M, Ito S, Taguchi H, Ishii T, Asai S, Hirata S, Ikeda K, Suzuki K, Kato N, Kaneko Y.   +11 more
europepmc   +1 more source

Janus kinase inhibitors: another potential for uveitis treatment? [PDF]

Ann Eye Sci
Emami S, Kaisari E, Janetos TM.
europepmc   +1 more source

Efficacy of Biologic Agents and Small Molecules for Endoscopic Improvement and Mucosal Healing in Patients with Moderate-to-Severe Ulcerative Colitis: Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Mademlis C, Katsoula A, Koufakis T, Paschos P, Kefas A, Teperikidis L, Theodoridou N, Giouleme O.   +7 more
europepmc   +1 more source

JAK1-selective inhibitors versus pan-JAK inhibitors: comparative real-world study of drug retention in chronic inflammatory arthritis. [PDF]

Ther Adv Musculoskelet Dis
Leon L, Bermejo PP, Laredo L, Peña Pedrosa JA, Benítez Gimenez MT, Freites D, de Miguel C, Abasolo L.   +7 more
europepmc   +1 more source

JAK Inhibitors and Risk of Cancer in IBD Patients. [PDF]

Cancers (Basel)
Bernardi F, Faggiani I, Parigi TL, Zilli A, Allocca M, Furfaro F, Peyrin-Biroulet L, Danese S, D'Amico F.   +8 more
europepmc   +1 more source

Post-marketing surveillance of upadacitinib: multilevel analysis of venous thromboembolism reporting in global data and rheumatoid arthritis. [PDF]

Front Med (Lausanne)
Ferreira-da-Silva R, Lobo M, Abreu AR, Pereira-Macedo J, Mós B, Rodriguez CA, Lourenço IM, Vieira I, Polónia JJ, Gouveia L, Silva L, Morato M, Pinto M, Forrester M, Pereira M, Rodrigues N, Biase T, Ribeiro I.   +17 more
europepmc   +1 more source